| Literature DB >> 30460058 |
Sin-Gu Jeong1,2, Youn Seo Oh1,2, I-Seul Joe1,2, So Young Jeong1, Hyo Moon Cho3, Jun Sik Lee1,2, Won Keun Oh3, Tae Oh Cho1, Goang-Won Cho1,2.
Abstract
The brown alga Undaria pinnatifida, which is called Mi-Yoek in Korea, has been traditionally consumed as a health food in East Asian countries. Recent studies have reported that U. pinnatifida has beneficial effects on arteriosclerosis, inflammation, fat metabolism, and tumors. In this study, we examined the anti-senescence effects of ethanol extracts of U. pinnatifida (UP-Ex) in human bone marrow mesenchymal stem cells (hBM-MSCs). UP-Ex protected hBM-MSCs against oxidative injury, as determined by MTT assays. This effect was confirmed by immunoblot analysis of the oxidation-sensitive protein p53 and the apoptotic protein cleaved caspase-3. Excessive intracellular reactive oxygen species (ROS) accumulation induced by oxidative stress was moderated in UP-Ex-treated hBM-MSCs (UP-Ex-MSCs). Similarly, expression of the ROS-scavenging enzymes superoxide dismutase 1 (SOD1), SOD2, and catalase was recovered in UP-Ex-MSCs. Excessive ROS induced by long-term cell expansion (passage 17) was significantly decreased along with restoration of the senescence proteins p53, p21, and p16 in UP-Ex-MSCs. UP-Ex treatment also improved the ability of these replicative, senescent hBM-MSCs (passage 17) to differentiate into osteocytes or adipocytes, suggesting that UP-Ex ameliorates the functional decline of senescent stem cells and may provide better therapeutic efficacy in stem cell therapy. Abbreviations: hBM-MSCs: human bone marrow mesenchymal stem cells; DCF: 2',7'-dichlorodihydrofluorescein; DCFH-DA: 2',7'-dichlorofluorescein diacetate; MTT: 3-(4,5-dimethylthiazol-2-yl-)2,5-diphenyltetrazolium bromide; PBS: phosphate-buffered saline; PFA: paraformaldehyde; RIPA: radioimmunoprecipitation assay; ROS: reactive oxygen species; SOD1: superoxide dismutase 1; SOD2: superoxide dismutase 2.Entities:
Keywords: Undaria pinnatifida; anti-oxidation; long-term expansion; mesenchymal stromal cells; replicative senescence
Year: 2017 PMID: 30460058 PMCID: PMC6138307 DOI: 10.1080/19768354.2017.1292951
Source DB: PubMed Journal: Anim Cells Syst (Seoul) ISSN: 1976-8354 Impact factor: 1.815
Figure 1.Cell-protective effects of U. pinnatifida extract (UP-Ex) in H2O2-treated hBM-MSCs. (a) hBM-MSCs were treated with 0–50 μg/mL UP-Ex (UP-Ex-MSCs) for 24 h and evaluated by an MTT assay. (b) hBM-MSCs were treated with 1 mM H2O2 following pre-incubation with UP-Ex (0–10 μg/mL) for 24 h and cell viability was measured by MTT assay. (c) UP-Ex-MSCs (5 μg/mL for 24 h) were exposed to 0–3 mM H2O2 for 1 h and the cell viability was evaluated by an MTT assay. Cell viability was significantly improved in UP-Ex-MSCs. (d) 5 μg/mL UP-Ex-MSCs were incubated with 1 mM H2O2 for 1 h. Total protein was examined by immunoblot analysis with antibodies against the apoptotic proteins p53, cleaved caspase-3, and β-actin. The protein expressions were quantified using the Image J software. β-actin was used as the internal standard.
Figure 2.U. pinnatifida extract (UP-Ex) treatment reduces intracellular ROS levels in hBM-MSCs. (a) UP-Ex-treated hBM-MSCs (UP-Ex-MSCs; 5 μg/mL for 24 h) were treated with 1 mM H2O2 for 1 h, and their iROS levels were observed by fluorescence microscopy (upper panel). Fluorescence levels were quantified with a fluorescence ELISA plate reader (lower panel). (b) Steady-state iROS levels were visualized in 0–5 μg/mL UP-Ex-MSCs (upper panel) and quantified by a fluorescence-based ELISA plate reader (lower panel). (c) UP-Ex-MSCs were treated with 1 mM H2O2 for 1 h. The expression of antioxidant enzymes SOD1, SOD2, and catalase was measured by immunoblot analysis. β-actin was used as the internal standard.
Figure 3.Restoration of antioxidant enzymes and reversal of senescence protein expression increases in U. pinnatifida extract (UP-Ex)-treated senescent hBM-MSCs. (a) Intracellular reactive oxygen species were detected with DCFH-Da in passage (P)-7, P-17, and UP-Ex-treated P-17 hBM-MSCs by fluorescence microscopy (left panel) and quantified using a fluorescence-based ELISA plate reader (right panel). (b) Total protein from P-7, P-17, and UP-Ex-treated P-17 hBM-MSCs were examined by immunoblot analysis with antibodies against SOD1, SOD2, catalase, and β-actin. (c) The expression of the senescence proteins p53, p21, and p16 was examined by immunoblot analysis. The bands in (b) and (c) were quantified by the Image J software and normalized with β-actin.
Figure 4.Improvement of differentiation potential in U. pinnatifida extract (UP-Ex)-treated senescent hBM-MSCs. (a) hBM-MSCs at passage (P)-7 or P-17, with or without UP-Ex treatment at P-17, were induced to differentiate into osteocytes (upper panels) and adipocytes (lower panels). Differentiation capacities were evaluated by alizarin red S or oil red O staining. (b) The Alizarin red S or oil red O stained cells were quantified using the Image J software.